IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities

Nature Medicine

Volumn 13, Issue 8, 2007, Pages 927-934

  Orinska, Zane ^a   Maurer, Marcus ^b   Mirghomizadeh, Farhad ^a   Bulanova, Elena ^a   Metz, Martin ^b,c   Nashkevich, Natalia ^a   Schiemann, Florian ^a   Schulmistrat, Jan ^a   Budagian, Vadim ^a   Giron Michel, Julien ^d   Brandt, Ernst ^a   Paus, Ralf ^e   Bulfone Paus, Silvia ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HÔPITAL PAUL BROUSSE   (France)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHYMASE; CYTOKINE; INTERLEUKIN 15;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL PERITONITIS; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; GRAM NEGATIVE BACTERIUM; INNATE IMMUNITY; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; TRANSCRIPTION REGULATION;

ANIMALS; CHEMOTAXIS; CHYMASES; DOWN-REGULATION; ESCHERICHIA COLI; GENE DELETION; INTERLEUKIN-15; MAST CELLS; MICE; MICE, KNOCKOUT; MONOCYTE CHEMOATTRACTANT PROTEINS; SEPSIS; SIGNAL TRANSDUCTION; SURVIVAL RATE; TRANSCRIPTION, GENETIC; UP-REGULATION;

MUS; NEGIBACTERIA;

EID: 34547670717     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1615     Document Type: Article

References (49)

1. Riedemann, N.C., Guo, R.F. & Ward, P.A. Novel strategies for the treatment of sepsis. Nat. Med. 9, 517-524 (2003).
2. Cohen, J. The immunopathogenesis of sepsis. Nature 420, 885-891 (2002).
3. Galli, S.J. et al. Mast cells as 'tunable' effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23, 749-786 (2005).
4. Marshall, J.S. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4, 787-799 (2004).
5. Echtenacher, B., Männel, D.N. & Hültner, L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381, 75-77 (1996).
6. Malaviya, R., Ikeda, T., Ross, E. & Abraham, N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNFα. Nature 381, 77-80 (1996).
7. Maurer, M. et al. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J. Exp. Med. 188, 2343-2348 (1998).
8. Bone-Larson, C.L. et al. Novel protective effects of stem cell factor in a murine model of acute septic peritonitis. Dependence on MCP-1. Am. J. Pathol. 157, 1177-1186 (2000).
9. Feger, F., Varadaradjalou, S., Gao, Z., Abraham, S.N. & Arock, M. The role of mast cells in host defense and their subversion by bacterial pathogens. Trends Immunol. 23, 151-158 (2002).
10. Huang, C., Sali, A. & Stevens, R.L. Regulation and function of mast cell proteases in inflammation. J. Clin. Immunol. 18, 169-183 (1998).
11. Gurish, M.F. et al. Differential expression of secretory granule proteases in mouse mast cells exposed to interleukin 3 and c-kit ligand. J. Exp. Med. 175, 1003-1012 (1992).
12. Miller, H.R., Wright, S.H., Knight, P.A. & Thornton, E.M. A novel function for transforming growth factor-β1: upregulation of the expression and the IgE-independent extracellular release of a mucosal mast cell granule-specific β-chymase, mouse mast cell protease-1. Blood 93, 3473-3486 (1999).
13. Ghildyal, N., McNeil, H.P., Gurish, M.F., Austen, K.F. & Stevens, R.L. Transcriptional regulation of the mucosal mast cell-specific protease gene, MMCP-2, by interleukin 10 and interleukin 3. J. Biol. Chem. 267, 8473-8477 (1992).
14. Mizutani, H., Schechter, N., Lazarus, G., Black, R.A. & Kupper, T.S. Rapid and specific conversion of precursor interleukin 1β (IL-1β) to an active IL-1 species by human mast cell chymase. J. Exp. Med. 174, 821-825 (1991).
15. Zhao, W., Oskeritzian, C.A., Pozez, A.L. & Schwartz, L.B. Cytokine production by skin-derived mast cells: endogenous proteases are responsible for degradation of cytokines. J. Immunol. 175, 2635-2642 (2005).
16. Bulfone-Paus, S., Bulanova, E., Budagian, V. & Paus, R. The interleukin-15/interleukin-15 receptor system as a model for juxtacrine and reverse signaling. BioEssays 28, 362-377 (2006).
17. Fehniger, T.A. & Caligiuri, M.A. Interleukin-15: biology and relevance to human disease. Blood 97, 14-32 (2001).
18. Budagian, V., Bulanova, E., Paus, R. & Bulfone-Paus, S. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 17, 259-280 (2006).
19. Hiromatsu, T. et al. Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-α- induced apoptosis. J. Infect. Dis. 187, 1442-1451 (2003).
20. Colucci, F., Caligiuri, M.A. & Di Santo, J.P. What does it take to make a natural killer? Nat. Rev. Immunol. 3, 413-425 (2003).
21. Bulfone-Paus, S. et al. Interleukin-15 protects from lethal apoptosis in vivo. Nat. Med. 3, 1124-1128 (1997).
22. Bulanova, E. et al. Mast cells express novel functional IL-15 receptor α isoforms. J. Immunol. 170, 5045-5055 (2003).
23. Buras, J.A., Holzmann, B. & Sitkovsky, M. Animal models of sepsis: setting the stage. Nat. Rev. Drug Discov. 4, 854-865 (2005).
24. Malaviya, R. & Abraham, S.N. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J. Leukoc. Biol. 67, 841-846 (2000).
25. Dvorak, A.M. Subcellular localization of the cytokines, basic fibroblast growth factor and tumor necrosis factor-α in mast cells. Chem. Immunol. Allergy 85, 72-88 (2005).
26. Knight, P.A., Wright, S.H., Thornton, E.M., Brown, J. & Miller, H.R.P. Expression, function and regulation of mast cell granule chymases during mucosal allergic responses. In: Mast Cells and Basophils (eds. Marone G., Lichtenstein L.M. & Galli S.J.) 257-273 (Academic, San Diego, 2000).
27. Schiemann, F. et al. Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counter-regulation by PF-4 through inhibition of chymase and cathepsin G. Blood 107, 2234-2242 (2006).
28. Maurer, M. et al. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 432, 512-516 (2004).
29. Calandra, T. et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 6, 164-170 (2000).
30. Moreno, S.E. et al. IL-12, but not IL-18, is critical to neutrophil activation and resistance to polymicrobial sepsis induced by cecal ligation and puncture. J. Immunol. 177, 3218-3224 (2006).
31. Wirtz, S. et al. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J. Exp. Med. 203, 1875-1881 (2006).
32. Kandere-Grzybowska, K. et al. IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J. Immunol. 171, 4830-4836 (2003).
33. Cao, J. et al. Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J. Immunol. 174, 7665-7675 (2005).
34. Strik, M.C. et al. Intracellular serpin SERPINB6 (PI6) is abundantly expressed by human mast cells and forms complexes with β-tryptase monomers. Blood 103, 2710-2717 (2004).
35. Feyerabend, T.B. et al. Loss of histochemical identity in mast cells lacking carboxypeptidase A. Mol. Cell. Biol. 25, 6199-6210 (2005).
36. Ilangumaran, S., Finan, D., Raine, J. & Rottapel, R. Suppressor of cytokine signaling 1 regulates an endogenous inhibitor of a mast cell protease. J. Biol. Chem. 278, 41871-41880 (2003).
37. Wilusz, C.J., Wormington, M. & Peltz, S.W. The cap-to-tail guide to mRNA turnover. Nat. Rev. Mol. Cell Biol. 2, 237-246 (2001).
38. Xia, Z., Ghildyal, N., Austen, K.F. & Stevens, R.L. Post-transcriptional regulation of chymase expression in mast cells. J. Biol. Chem. 271, 8747-8753 (1996).
39. de Garavilla, L. et al. A novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase: molecular mechanisms and anti-inflammatory activity in vivo. J. Biol. Chem. 280, 18001-18007 (2005).
40. Lindstedt, K.A. et al. Activation of paracrine TGF-b1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase. FASEB J. 15, 1377-1388 (2001).
41. Nabah, Y.N. et al. Angiotensin II induces neutrophil accumulation in vivo through generation and release of CXC chemokines. Circulation 110, 3581-3586 (2004).
42. Kunori, Y. et al. Rodent α-chymases are elastase-like proteases. Eur. J. Biochem. 269, 5921-5930 (2002).
43. Solivan, S., Selwood, T., Wang, Z.M. & Schechter, N.M. Evidence for diversity of substrate specificity among members of the chymase family of serine proteases. FEBS Lett. 512, 133-138 (2002).
44. Di Nardo, A., Vitiello, A. & Gallo, R.L. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol. 170, 2274-2278 (2003).
45. Yang, D. et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192, 1069-1074 (2000).
46. Lodolce, J.P. et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9, 669-676 (1998).
47. Kennedy, M.K. et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15 - deficient mice. J. Exp. Med. 191, 771-780 (2000).
48. Pasparakis, M., Alexopoulou, L., Episkopou, V. & Kollias, G. Immune and inflammatory responses in TNF α-deficient mice: a critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184, 1397-1411 (1996).
49. + T-cell recruitment. Blood 106, 978-987 (2005).